Dipraglurant Recruiting Phase 2 Trials for Blepharospasm / Dystonia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05027997Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm